| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion due to NICE appraisal TA235: Mifamurtide for the treatment of osteosarcoma |
|
Medicine details |
|
| Medicine name | mifamurtide (Mepact®) |
| Formulation | powder for suspension for infusion |
| Reference number | 203 |
| Indication | Treatment of high-grade resectable non-metastatic osteosarcoma in children, adolescents and young adults after macroscopically complete surgical resection, in combination with post-operative multi-agent chemotherapy |
| Company | Takeda UK Ltd |
| BNF chapter | Malignant disease & immunosuppression |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 26/08/2008 |
| NICE guidance | |